Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

A medical elongated body including a catheter main body. The catheter main body has a tubular body and a lumen. The tubular body includes a guide wire lumen into which a guide wire is insertable. The tubular body also a distal member positioned at the distal portion of the tubular body. The distal member has a lumen that communicates with the guide wire lumen. The inner diameter of the distal member decreases between the proximal end and a distal end opening of the distal member. The medical elongated body also includes a visible marker that extends circumferentially on the outer surface of the distal member to indicate a position of the distal member in the axial direction corresponding to a predetermined inner diameter of the distal member. The visible marker is visible before the medical elongated body is inserted into a living body.

A gastric tube for use in a bariatric surgical procedure includes an elongate tube and an anchor. The elongate tube has a proximal end portion and a distal end portion and defines a lumen along a length thereof. The proximal end portion defines an opening in communication with the lumen. The elongate tube includes a blunt tip, a light source, and an outer surface. The blunt tip is formed on the distal end portion and is at least partially transparent. The light source is in communication with the blunt tip for illuminating at least the blunt tip. The outer surface extends between the proximal and distal end portions and defines a side opening in communication with the lumen.

Origami robots, and associated systems, methods of treatment, and methods of manufacture are provided. A system includes an origami robot encapsulated for ingestion by a patient, such as in a biocompatible material that is dissolvable or meltable within the gastrointestinal tract. A method of treatment includes delivering an origami robot in a folded position into a gastrointestinal tract of a patient, causing the origami robot to unfold within the gastrointestinal tract, and directing the origami robot to a site requiring treatment in the gastrointestinal tract.

An ingestible apparatus for collecting samples from a target area of a gastrointestinal tract of a human or mammal and/or for delivering a health-related fluid thereto. The ingestible apparatus has a housing comprising at least one first port and at least a volume-changeable first compartment fluidly communicable with the at least one first port, an actuation assembly for changing the volume of the first compartment for collecting the samples and/or discharging the health-related fluid through the at least one first port, a delay structure for delaying the actuation assembly to change the volume of the first compartment until the ingestible apparatus is at or about the target area, and a circuit structure for detecting arrival of the ingestible apparatus at the target area and for detecting an end of the sample collecting and/or the health-related-fluid discharging.

The drainage catheter according to the examples of the present invention comprises a first induction conduit; and a second induction conduit having a circumference part surrounding the first induction conduit, in which a cut part is formed so that a front edge of the first induction conduit is exposed to the outside.

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Disclosed is a localized method for treatment of cancer including the steps of providing a drug delivery catheter; navigating the catheter to the bile duct; and delivering a therapeutic agent into the bile duct. According to one aspect of the method, the drug delivery catheter is a multi-occlusion balloon catheter. The multi-occlusion balloon catheter may include at least two balloons. The multi-occlusion balloon catheter may optionally include a pressure transducer between the balloons to optimize delivery technique.

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.